Evidence map›Paper›PMID 33479349›Full record

ArticleScientific reports2021

Acetyl-CoA flux from the cytosol to the ER regulates engagement and quality of the secretory pathway.

Inca A Dieterich, Yusi Cui, Megan M Braun, Alexis J Lawton, Nicklaus H Robinson, Jennifer L Peotter, Qing Yu, Jason C Casler, Benjamin S Glick, Anjon Audhya and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. CaScientific reports · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Boost-DiLeu: Enhanced IsobaricAnalytical chemistry · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Inca A Dieterich *Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Yusi Cui *School of Pharmacy and Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
Megan M BraunDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Alexis J LawtonDepartment of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
Nicklaus H RobinsonDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Jennifer L PeotterDepartment of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
Qing YuSchool of Pharmacy and Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
Jason C CaslerDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL, USA.
Benjamin S GlickDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL, USA.
Anjon AudhyaDepartment of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
John M DenuDepartment of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
Lingjun LiSchool of Pharmacy and Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA. lingjun.li@wisc.edu.
Luigi PuglielliDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA. lp1@medicine.wisc.edu.
University of Wisconsin–Madison · USUniversity of Chicago · USHarvard University · USWisconsin Institutes for Discovery · US

Funding

Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
TR&D 2 Metabolic Labels for Ultraplexed Protein Quantification p. 453P41GM108538 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI COON, JOSHUA J · 2016 to 2025
$13.1M
Biology of Aging and Age-Related Diseases Training GrantT32AG000213 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Rozalyn M. Anderson, Sanjay Asthana · 1991 to 2026
$9.9M
Reversible protein acetylation and sirtuin functionR01GM065386 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI DENU, JOHN M · 2003 to 2022
$7.3M
Mass Spectrometric Studies of Neuropeptides in FeedingR01DK071801 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI LINGJUN LI · 2006 to 2026
$6.7M
Waisman Intellectual and Developmental Disabilities Research Center Down Syndrome RegistryU54HD090256 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 2016 to 2020
$6.0M
Training Program In Molecular AND Cellular PharmacologyT32GM008688 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 1998 to 2020
$6.0M
Molecular mechanisms that regulate vesicle formation and transportR35GM134865 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anjon Audhya · 2020 to 2026
$4.8M
Spastic paraplegia, neurodegeneration and autism: possible role for AT- 1/SLC33A1?R01NS094154 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Luigi Puglielli · 2015 to 2026
$4.3M
Acetyl-CoA flux and mitochondrial adaptation: a pathogenic role in aging and AD?RF1AG057408 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, ROZALYN M., PUGLIELLI, LUIGI · 2017 to 2017
$3.5M
Dissecting the functions of yeast COPI - Resubmission 01R01GM104010 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S · 2013 to 2020
$3.2M
Molecular Mechanisms that Regulate Lysosomal Protein TransportR01GM088151 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 2010 to 2019
$3.0M
BLRD VA I01 BX004202NCRR NIH HHS S10 RR029531NIA NIH HHS RF1 AG052324NIA NIH HHS RF1 AG053937NIA NIH HHS RF1 AG057408NIA NIH HHS T32 AG000213NICHD NIH HHS U54 HD090256NIDDK NIH HHS R01 DK071801NIGMS NIH HHS P41 GM108538NIGMS NIH HHS R01 GM065386NIGMS NIH HHS R01 GM088151NIGMS NIH HHS R01 GM104010NIGMS NIH HHS R01 GM110567NIGMS NIH HHS R35 GM134865NIGMS NIH HHS T32 GM007183NIGMS NIH HHS T32 GM008688NIH HHS DK071801NIH HHS GM065386NIH HHS GM104010NIH HHS GM134865NIH HHS NS094154NINDS NIH HHS R01 NS094154NINDS NIH HHS T32 NS105602VA I01 BX004202
6 · The paper itself

Abstract

Nε-lysine acetylation in the ER is an essential component of the quality control machinery. ER acetylation is ensured by a membrane transporter, AT-1/SLC33A1, which translocates cytosolic acetyl-CoA into the ER lumen, and two acetyltransferases, ATase1 and ATase2, which acetylate nascent polypeptides within the ER lumen. Dysfunctional AT-1, as caused by gene mutation or duplication events, results in severe disease phenotypes. Here, we used two models of AT-1 dysregulation to investigate dynamics of the secretory pathway: AT-1 sTg, a model of systemic AT-1 overexpression, and AT-1

Indexed as

AcetylationAcetyl Coenzyme AAcetyltransferasesAutophagyCytosolEndoplasmic ReticulumGene Expression RegulationGolgi ApparatusHaploinsufficiencyHumansLysosomesMembrane Transport ProteinsMutationProtein Processing, Post-TranslationalProtein TransportSecretory PathwayAcetyl Coenzyme AAcetyltransferasesMembrane Transport ProteinsSLC33A1 protein, human

Identifiers

PMID33479349
PMCPMC7820588
OpenAlexW3122477652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.